Register entryRepackager / relabeller

Legacy Pharma USA Inc.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
29
Labeller names
3
Live patents
0
Countries
1
Base
United States
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Legacy Pharma USA Inc.15169 N Scottsdale Rd, Ste 205, Scattsdale, Arizona (AZ) 85254-2665, United States (USA)Labelling3038507464118831776
Catalogue

Drug listings by form and route

29

29 active NDC listings: 28 human prescription drug, 1 drug for further processing. By marketing category: NDA 19, ANDA 7, UNAPPROVED DRUG OTHER 2, DRUG FOR FURTHER PROCESSING 1.

Dosage formNDCs
tablet11
capsule5
cream4
lotion3
ointment2
tablet, coated2
gel1
injection1
RouteNDCs
oral17
topical10
intravenous1
Labeller name on the listingNDCs
legacy pharma usa inc.17
legacy pharma usa, inc.11
legacy pharma usa inc1
Catalogue

Marketed products

29
BrandGeneric nameForm / routeNDC
Analpram HChydrocortisone acetate and pramoxine hydrochloridecream, topical83107-018ANDA
Analpram HChydrocortisone acetate and pramoxine hydrochloridecream, topical83107-019ANDA
Analpram HChydrocortisone acetate and pramoxine hydrochloridelotion, topical83107-020ANDA
BETAPACEsotalol hydrochloridetablet, oral83107-005NDA
BETAPACEsotalol hydrochloridetablet, oral83107-006NDA
BETAPACEsotalol hydrochloridetablet, oral83107-007NDA
BETAPACE AFsotalol hydrochloridetablet, oral83107-008NDA
BETAPACE AFsotalol hydrochloridetablet, oral83107-009NDA
BETAPACE AFsotalol hydrochloridetablet, oral83107-010NDA
BRISDELLEparoxetinecapsule, oral83107-027NDA
ESBRIETPIRFENIDONEtablet, coated, oral83107-028NDA
ESBRIETPIRFENIDONEtablet, coated, oral83107-029NDA
EthyolAmifostineinjection, intravenous83107-030NDA
IMURANazathioprinetablet, oral83107-025NDA
LOTRONEXalosetron hydrochloridetablet, oral83107-012NDA
LOTRONEXalosetron hydrochloridetablet, oral83107-013NDA
Motofendifenoxin and atropine sulfatetablet, oral83107-011NDA
NaftinNaftifine Hydrochloridegel, topical83107-023NDA
Pramosonehydrocortisone acetate and pramoxine hydrochlorideointment, topical83107-014UNAPPROVED DRUG OTHER
Pramosonehydrocortisone acetate and pramoxine hydrochloridelotion, topical83107-021ANDA
Pramosonehydrocortisone acetate and pramoxine hydrochloridelotion, topical83107-022ANDA
Pramosone Creamhydrocortisone acetate and pramoxine hydrochloridecream, topical83107-016ANDA
Pramosone Creamhydrocortisone acetate and pramoxine hydrochloridecream, topical83107-017ANDA
Zanaflextizanidine hydrochloridecapsule, oral83107-001NDA
Zanaflextizanidine hydrochloridecapsule, oral83107-002NDA
Zanaflextizanidine hydrochloridecapsule, oral83107-003NDA
Zanaflextizanidine hydrochloridetablet, oral83107-004NDA
-paroxetinecapsule83107-031DRUG FOR FURTHER PROCESSING
pramosonehydrocortisone acetate and pramoxine hydrochlorideointment, topical83107-015UNAPPROVED DRUG OTHER
Compare

Comparable companies in United States

Enquiry

Common questions

Is Legacy Pharma USA Inc. FDA approved?
Legacy Pharma USA Inc. holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Legacy Pharma USA Inc.'s registered sites?
The FDA register lists Scattsdale, AZ. Registered operations: labelling.
What drugs does Legacy Pharma USA Inc. make?
29 products are listed under Legacy Pharma USA Inc. in the openFDA NDC Directory, most often as tablet; capsule; cream. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.